Enhancing oral vaccine potency by targeting intestinal M cells - Wikidata - awgldk - TriplyDB

Enhancing oral vaccine potency by targeting intestinal M cells

Enhancing oral vaccine potency by targeting intestinal M cells

http://www.wikidata.org/entity/Q21089613

about

Plant-based oral vaccines against zoonotic and non-zoonotic diseases Plant-made oral vaccines against human infectious diseases-Are we there yet?Use of lectin-functionalized particles for oral immunotherapy The adjuvanticity of an O. volvulus-derived rOv-ASP-1 protein in mice using sequential vaccinations and in non-human primates The osmotic stress response of split influenza vaccine particles in an acidic environment.Botulinum toxin A complex exploits intestinal M cells to enter the host and exert neurotoxicity.Screening of surface markers on rat intestinal mucosa microfold cells by using laser capture microdissection combined with protein chip technology.Loss of sialic acid binding domain redirects protein σ1 to enhance M cell-directed vaccination Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.In vitro and in vivo characterization of DNA delivery using recombinant Lactococcus lactis expressing a mutated form of L. monocytogenes Internalin A.A mechanistic study on the destabilization of whole inactivated influenza virus vaccine in gastric environment.Cellobiose-coated poly(lactide-co-glycolide) particles loaded with diphtheria toxoid for per os immunization.Mucosal delivery of ACNPV baculovirus driving expression of the Gal-lectin LC3 fragment confers protection against amoebic liver abscess in hamster.Roles of M cells in infection and mucosal vaccines.Mucosal Immune System and M Cell-targeting Strategies for Oral Mucosal Vaccination.Formulation and delivery of vaccines: Ongoing challenges for animal management.Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation Alga-produced cholera toxin-Pfs25 fusion proteins as oral vaccines.Immune Tolerance for Autoimmune Disease and Cell Transplantation Mechanisms Underlying the Immune Response Generated by an Oral Vibrio cholerae Vaccine.Targeted Delivery of VP1 Antigen of Foot-and-mouth Disease Virus to M Cells Enhances the Antigen-specific Systemic and Mucosal Immune Response.Mucosal Lactobacillus vectored vaccines.Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines.Enterocytes: active cells in tolerance to food and microbial antigens in the gut.The role of CD103⁺ dendritic cells in the intestinal mucosal immune system.The immunomodulatory effect of plant lectins: a review with emphasis on ArtinM properties.Transepithelial antigen delivery in the small intestine: different paths, different outcomes.Intranasal formulations: promising strategy to deliver vaccines.Oral delivery of nanoparticle-based vaccines.Novel antigen delivery technologies: a review.Mucosal vaccine delivery: Current state and a pediatric perspective Outer membrane vesicles induce immune responses to virulence proteins and protect against colonization by enterotoxigenic Escherichia coli.Surface-modified P(HEMA-co-MAA) nanogel carriers for oral vaccine delivery: design, characterization, and in vitro targeting evaluation.Characterization and evaluation of stabilized particulate formulations as therapeutic oral vaccines for allergy.Current state and challenges in developing oral vaccines.Surface display of N-terminally anchored invasin by Lactobacillus plantarum activates NF-κB in monocytes.Vaccination against Salmonella Infection: the Mucosal Way.Delivery of immunogens to mucosal immune system using an oral inactivated cholera vaccine: a new approach for development of oral vaccines.Liposomal α-galactosylceramide is taken up by gut-associated lymphoid tissue and stimulates local and systemic immune responses.Recent developments in nanocarrier-aided mucosal vaccination.

P2860

Q26738581-6CEFE1D0-AD2E-430B-9AEF-78BFD868BC48 Q26783111-BB7BCBE8-1517-408B-B602-7CD68A7ED253 Q26849550-58C41A89-2A22-4891-A9A1-D5E939872F44 Q28729899-6E71701A-B3F8-4E53-848E-C58361B4DC5F Q30354213-C2BFD5E3-868D-4239-BF31-F50B87809BFA Q30621197-06655286-6D2E-4008-92A5-2886E0BA13AB Q33756249-2B98B651-EEC1-4BF6-B54B-52E8FB71C0C3 Q34257271-49C87D2D-510C-4CA6-A8B7-C143D41DCF92 Q34455041-A7DAE2D6-E269-477C-8B5D-6C081448E002 Q34518201-D8D0FD1D-4BE1-4EA1-A515-DB755678C1A3 Q34776559-E8807070-9213-44BE-8CCA-51E3566CB080 Q35539544-DA62B869-04AD-4E27-BAC6-246CB3B552AF Q35565185-04E6E8ED-A876-4CDC-AD84-FB7D488CE9FB Q35886575-E4A016F8-7052-4DE9-8727-9FD7DF64D83E Q36431001-E11CEFB0-39EC-4661-A052-655BD130DCDE Q36470265-CEFB542C-48B6-43E2-B09E-7B0279DB8CCD Q36598433-75FAFD72-3941-4539-9C82-F53F75BEC6D8 Q36970645-8D24E815-2F5B-4A3F-B03F-3792028B79A0 Q37099107-A2D8C4A0-D0AE-4336-87D1-2FCDD94470E8 Q37134468-5412EF88-A118-4E42-98B2-3AC6FFBA0996 Q37138636-A5B71ACF-BA4D-40B8-A458-6844FCC0764F Q37521871-E33B6BF5-CD8A-4021-99E1-A63320B5B93A Q37679436-1E6E2ED3-D343-4E83-AA92-05C0C04B1CD8 Q37979863-A180350E-C37F-444C-88B6-2F30BE65DE86 Q38008332-6EED877A-E1FC-43EA-9647-8214C031B2D5 Q38072603-283C0AD7-BEB7-446C-892A-35A0AE860BCC Q38079085-17741277-7FA3-4FD9-AA15-099443B867C2 Q38223050-F928FCC7-04A2-46ED-8AFD-873E7334280A Q38243119-2879B1CB-D932-4B29-B3D4-997E2D2E1EAF Q38383368-48256F70-1B86-4367-BE78-3B5EEF76BEE1 Q38727453-C33F5D1E-BF75-43D7-962E-8C4DFBA84452 Q38955024-779FC044-89A8-43E1-A7EF-7DDA48A3915E Q38982074-17F6891D-C64F-4E75-81CF-6C7FFA1FFADD Q39151148-4A232F68-86EB-4F8F-A1A0-860E6EA3FB9E Q39259629-42406290-C7DD-46AA-A9E5-5B4F23236F57 Q39329973-862E6225-62E5-4D4A-A70E-A4AC9D925F1E Q39373957-8B2DF21F-D204-4059-8F61-1B2ACD91F43D Q39456108-2EE09EB2-E75F-48A7-A9FE-C5DCAF2496F7 Q40066630-AFC0E2E8-FD97-4652-B13A-6C150D5DD519 Q40228907-879A770B-0EDB-4E64-B3D5-300840D9D6AD

P2860

Enhancing oral vaccine potency by targeting intestinal M cells

http://www.wikidata.org/entity/Q21089613

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Enhancing oral vaccine potency by targeting intestinal M cells

@ast

Enhancing oral vaccine potency by targeting intestinal M cells

@en

Enhancing oral vaccine potency by targeting intestinal M cells

@en-gb

Enhancing oral vaccine potency by targeting intestinal M cells

@nl

type

label

Enhancing oral vaccine potency by targeting intestinal M cells

@ast

Enhancing oral vaccine potency by targeting intestinal M cells

@en

Enhancing oral vaccine potency by targeting intestinal M cells

@en-gb

Enhancing oral vaccine potency by targeting intestinal M cells

@nl

prefLabel

Enhancing oral vaccine potency by targeting intestinal M cells

@ast

Enhancing oral vaccine potency by targeting intestinal M cells

@en

Enhancing oral vaccine potency by targeting intestinal M cells

@en-gb

Enhancing oral vaccine potency by targeting intestinal M cells

@nl

P1433

Q21089613-072AEEDC-C8C9-4409-8154-74ED903D4916

P1476

Q21089613-30BAF59D-8FC5-4ABE-8A1D-2E364F91B049

P2093

Q21089613-0457B7FE-C153-43ED-B7BA-64CB5DD583BF

Q21089613-56B7BEED-A09C-4083-A43A-F2D715CE9435

Q21089613-B576404C-0A8E-4B15-A14E-9572A12F7D9A

Q21089613-B71B7EA5-FA22-4316-8BBC-4EBDA1775CE7

P275

Q21089613-D5B491E4-FD33-45EC-8DE0-0ED1021BEE65

P2860

Q21089613-035DEED5-20F4-447E-A0E9-70750C279316

Q21089613-046ADA12-8C3E-4C33-8296-AABFC907004A

Q21089613-0528FED1-8E44-4B5E-AB90-1948AC9C3474

Q21089613-06D548D2-FA06-4DD1-8AF1-45BB54EC1D77

Q21089613-0B5F8EFE-6C83-4571-B76F-0768DF0FAFC5

Q21089613-0F918C53-E929-4DA4-A2AB-5A038D9C41B6

Q21089613-146995DC-1A8E-4899-90FC-84F9EA0FA03C

Q21089613-1B5B88AE-C8A6-4046-B940-836DFBE9D974

Q21089613-1F92810A-36D8-428D-98EF-A987CDB27322

Q21089613-21638A4A-A4E7-44B7-BB28-F266DFEEB694

P304

Q21089613-B4A257E4-2BB9-4ED9-BDCC-5263FE735284

P31

Q21089613-9614CB06-0863-4DF9-BBAD-D06BA0250D43

Q21089613-A1A674DB-015B-490F-B20E-E13795907290

P3181

Q21089613-63A39A6A-EE7C-41BF-A06F-0ABCA9E107B2

P356

Q21089613-6C853379-076A-45B2-83CC-CC7D24D8AAF2

P407

Q21089613-994C5D2A-3016-4681-9F37-D0DB5BA42100

P433

Q21089613-08E823AD-055F-4A12-AA28-B736F6B44B99

P478

Q21089613-F7BC9218-B2EA-4DAC-8E47-70956D5B077F

P577

Q21089613-79C3D5C0-9B3C-46E1-92FD-73B9181D79E7

P5875

Q21089613-E1156BA6-AAD9-4763-9E57-08E2756F5BE4

P698

Q21089613-BFD731EB-1ED2-4FB1-8880-26662840D229

P921

Q21089613-3d468b3a-438e-6834-6269-5c48d47b96fc

Q21089613-7129e532-4702-ebe7-a613-9a34e4b0dc04

Q21089613-77ED5131-8716-4944-9FC7-42C913392EC1

Q21089613-CAB9A273-51CC-4EE8-8F50-D01D3FD13A4B

Q21089613-bc4788cf-4639-c7a4-8c11-40b8476c386e

P932

Q21089613-5998D021-BE9D-4071-8426-7DCE4182321E

P3181

P356

JOURNAL.PPAT.1001147

P1433

P1476

Enhancing oral vaccine potency by targeting intestinal M cells

@en

P2093

Ali Azizi

http://www.w3.org/2001/XMLSchema#string

Ashok Kumar

http://www.w3.org/2001/XMLSchema#string

Francisco Diaz-Mitoma

http://www.w3.org/2001/XMLSchema#string

Jiri Mestecky

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting

Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli

Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response

Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses

Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization.

Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products.

Impact of chitosan coating of anionic liposomes on clearance rate, mucosal and systemic immune responses following nasal administration in rabbits.

M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B.

Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin.

M cells at locations outside the gut.

P304

e1001147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4459975

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PPAT.1001147

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47812888

http://www.w3.org/2001/XMLSchema#string

P698

21085599

http://www.w3.org/2001/XMLSchema#string

P921

drug delivery system

intestinal mucosa

P932

2978714

http://www.w3.org/2001/XMLSchema#string